ACE inhibitors were able to reduce hypertension either by the suppression of angiotensin II biosynthesis or by the stimulation of bradykinin breakdown; ADA inhibitors were responsible for the alteration in adenosine and deoxyadenosine levels and in lymphocytic growth and functions, and enhance the effects of chemotherapeutic effects of adenosine analogs. This evidence concerns the gene ACE and hypertensive disorder.